Five factors driving up the cost of oncology drugs
The high cost of specialty drugs continues to plague the healthcare industry. Here’s why.
Read More
Four reasons COPD patients don’t receive the right treatments
Many providers are overlooking important steps that can help guide proper COPD treatment and therefore, reduce admissions and readmissions.
Six things to know about CMS' new bundled payment model
CMS unveiled a voluntary episode bundled payment model, Bundled Payments for Care Improvement Advanced (BPCI Advanced). Here’s six things experts want you to know
Despite hype, private payers slow to adopt oncology value-based models
Oncology Institute’s Dawn Holcombe, MBA, FACMPE, ACHE, shares her views on the OCM program, what CAR T-cell therapy means for the future of reimbursement, and some epic predictions.
Four things to know about your millennial workforce
How actively engaging millennials can help manage healthcare staffing challenges.
Trump’s impact on ACA enrollment: What you need to know
How did Trump’s actions in 2017 impact the health insurance marketplace and enrollment numbers? Find out.
Four COPD treatment changes to watch
Pending and recently approved treatment options for patients with chronic obstructive pulmonary disease range from biologics to a triple-drug inhaler.
FDA takes tough stance on kids’ opioid cold meds
FDA is taking its toughest stance yet on opioid-containing cough and cold medications for children.
FDA approves first drug for breast cancer with BRCA gene
FDA approved the first drug to treat certain patients with metastatic breast cancer who have a “BRCA” gene mutation.
How health execs can partner with pharmacists to address opioids
Director of medication safety and quality for the American Society of Health-System Pharmacists shares how providers can better work with pharmacists to address the opioid epidemic.
Most employees unsatisfied with employers' well-being programs
Willis Towers Watson research finds a dramatic increase among employers seeking to differentiate their health and well-being programs for competitive advantage.
Lessons learned from program to improve healthcare information exchange
One major piece of interoperability is the expanded use of admission, discharge, and transfer (ADT) notifications across provider networks.
Three ways healthcare executives can uncover consumers at risk for flu
With influenza activity increasing sharply, here’s how healthcare executives can determine which health plan members are at risk for the flu.
CAR T-cell therapies in treating lymphoma: Pros and cons
Catherine Bollard, MD, discusses the success rate of CAR T-cell treatments, remaining obstacles, and top payer considerations.
Four of the biggest challenges faced by health information organizations
Four health information organizations recently convened to discuss their challenges and successes in interoperability stability and infrastructure.
Three ways to combat sexual harassment in healthcare organizations
More reports of sexual harassment in the workplace are arising every day. It’s time to rethink your prevention strategies.
Expansion of association health plans: 6 things to know about Trump’s proposal
Trump’s new proposal would broaden access to association health plans. Here’s six things to know.
Drug shortage help on horizon
While hospitals continue to face IV saline shortages after two hurricanes significantly damaged infrastructure in Puerto Rico, the situation should improve early this year.
Top 10 challenges for healthcare executives in 2018
Managed Healthcare Executive board members identify top challenges. How does your list compare?
The top three pharmacy challenges of 2018
Find out what challenges top the list, and what analysts say can be done about them.
Will biosimilars deliver on expectations?
This might be the year when it becomes clear, perhaps painfully so, whether or not biosimilars can deliver on cost savings expectations.
Eight ways doctors can address the opioid epidemic
As the opioid epidemic rages, doctors and hospitals should consider these tips and strategies employed by other organizations.
End-of-life care planning advancements: What health execs should know
More awareness and new state laws regarding end-of-life treatment are affecting treatment approaches. Here’s what you need to know.
Autoimmune drug pipeline highlights
More targeted therapies for autoimmune diseases are on the horizon. Here’s what to anticipate in 2018.
Five changes healthcare executives can expect in 2018
The winds of change swept through healthcare in 2017. Here’s what 2018 could bring.
How Independence Health Group diversifies its workforce
The president and chief executive officer describes the various initiatives the organization is taking, and how they are resulting in big payoffs.
Four PBM programs poised to rein in the opioid epidemic
PBMs are in a unique position to help curb opioid abuse. Here are four programs that demonstrate promising outcomes.
Four health programs successfully fight the opioid epidemic
Shocking opioid overdose statistics make it crucial to address the epidemic. Here are four programs to watch
Two ways to improve health by addressing whole person care
By recognizing and address the needs of the “whole person,” we have an opportunity to improve the health of people across the U.S. Here are two ways to do that.
Four risks healthcare executives should monitor in 2018
With the right preventions in place, hospitals and healthcare executives will be well positioned to respond to these four risks in 2018.
